Top Story

Anti-CD73 antibody agent appears safe, shows promise in advanced cancers

November 8, 2019

Read the Perspective from Randy Sweis, MD

FDA News

FDA restructures, renames office that reviews cancer therapies

November 6, 2019
The FDA office that reviews applications for cancer therapies has been renamed and reorganized. The Center for Drug Evaluation and Research’s Office of Oncologic…
In the JournalsPerspective

Power morcellation technique increases mortality risk for women with occult uterine sarcoma

October 11, 2019
Uncontained power morcellation appeared associated with increased risk for mortality among women with occult uterine sarcoma, according to study results published in…
Orthopedics Today Grand Rounds

A 75-year-old woman with constitutional symptoms, precipitous functional decline

Orthopedics Today, September 2019
Bayard C. Carlson, MD; Douglas W. Bartels, MD; Joshua D. Johnson, MD; Peter S. Rose, MD
A 75-year-old woman with a medical history significant for obesity, diabetes mellitus type 2 and coronary artery disease presented with a 6-month history of…
More Headlines »

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »
Meeting News

VIDEO: Anti-CD47 fusion protein well tolerated by patients with solid tumors, non-Hodgkin lymphoma

June 24, 2018
More »

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker

There is no commercial support for this activity.

Ace the Case: A 67-Year-Old White Male Who Is a Former Smoker
More »